Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Prins

Showing results (31-40 of 153) with videos related to

Pageof 16
Sort By:
BMC Medical Imaging|October 19, 2011
Estimating radiation effective doses from whole body computed tomography scans based on U.S. soldier patient height and weightRobert D Prins, Raymond H Thornton, C Ross Schmidtlein, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 20, 2012
Cyclooxygenase isoenzyme-2 and vascular endothelial growth factor are associated with poor prognosis in esophageal adenocarcinomaM J D Prins, R J J Verhage, F J W ten Kate, et al.
Journal of Neural Transmission. Supplementum|November 29, 2002
Frequency of white matter lesions and silent lacunar infarctsE J van Dijk, N D Prins, S E Vermeer, et al.
The New England Journal of Medicine|March 28, 2003
Silent brain infarcts and the risk of dementia and cognitive declineSarah E Vermeer, Niels D Prins, Tom den Heijer, et al.
The Journal of Prevention of Alzheimer'S Disease|May 6, 2024
Phase 2A Learnings Incorporated into RewinD-LB, a Phase 2B Clinical Trial of Neflamapimod in Dementia with Lewy BodiesN D Prins, W de Haan, A Gardner, et al.
Journal of Clinical Pathology|September 18, 2013
Evaluation of the HER2 amplification status in oesophageal adenocarcinoma by conventional and automated FISH: a tissue microarray studyM J D Prins, J P Ruurda, P J van Diest, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2013
The significance of the HER-2 status in esophageal adenocarcinoma for survival: an immunohistochemical and an in situ hybridization studyM J D Prins, J P Ruurda, P J van Diest, et al.
Neurology|November 13, 2002
Homocysteine and cognitive function in the elderly: the Rotterdam Scan StudyN D Prins, T Den Heijer, A Hofman, et al.
Stroke|July 19, 2008
Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan studyEwoud J van Dijk, Niels D Prins, Henri A Vrooman, et al.
Journal of Clinical Pathology|November 20, 2012
Over-expression of phosphorylated mammalian target of rapamycin is associated with poor survival in oesophageal adenocarcinoma: a tissue microarray studyMargriet J D Prins, Roy J J Verhage, Jelle P Ruurda, et al.
Pageof 16

Showing results (31-40 of 153) with videos related to

Sort By:
Pageof 16
BMC Medical Imaging|October 19, 2011
Estimating radiation effective doses from whole body computed tomography scans based on U.S. soldier patient height and weightRobert D Prins, Raymond H Thornton, C Ross Schmidtlein, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 20, 2012
Cyclooxygenase isoenzyme-2 and vascular endothelial growth factor are associated with poor prognosis in esophageal adenocarcinomaM J D Prins, R J J Verhage, F J W ten Kate, et al.
Journal of Neural Transmission. Supplementum|November 29, 2002
Frequency of white matter lesions and silent lacunar infarctsE J van Dijk, N D Prins, S E Vermeer, et al.
The New England Journal of Medicine|March 28, 2003
Silent brain infarcts and the risk of dementia and cognitive declineSarah E Vermeer, Niels D Prins, Tom den Heijer, et al.
The Journal of Prevention of Alzheimer'S Disease|May 6, 2024
Phase 2A Learnings Incorporated into RewinD-LB, a Phase 2B Clinical Trial of Neflamapimod in Dementia with Lewy BodiesN D Prins, W de Haan, A Gardner, et al.
Journal of Clinical Pathology|September 18, 2013
Evaluation of the HER2 amplification status in oesophageal adenocarcinoma by conventional and automated FISH: a tissue microarray studyM J D Prins, J P Ruurda, P J van Diest, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2013
The significance of the HER-2 status in esophageal adenocarcinoma for survival: an immunohistochemical and an in situ hybridization studyM J D Prins, J P Ruurda, P J van Diest, et al.
Neurology|November 13, 2002
Homocysteine and cognitive function in the elderly: the Rotterdam Scan StudyN D Prins, T Den Heijer, A Hofman, et al.
Stroke|July 19, 2008
Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan studyEwoud J van Dijk, Niels D Prins, Henri A Vrooman, et al.
Journal of Clinical Pathology|November 20, 2012
Over-expression of phosphorylated mammalian target of rapamycin is associated with poor survival in oesophageal adenocarcinoma: a tissue microarray studyMargriet J D Prins, Roy J J Verhage, Jelle P Ruurda, et al.
Pageof 16